Compared with no antidepressant use, there was a significantly reduced risk of non-exudative AMD and exudative AMD with use of SSRIs, SNRIs, or tricyclic antidepressants. Depression and AMD share ...

Please provide your email address to receive an email when new articles are posted on . In a panel discussion on dry age-related macular degeneration during the session Section XIV: Non-exudative AMD, ...

An international collaboration of scientists publishing in Nature Reviews Disease Primers this week advocate for a new way of thinking about and finding treatments for age-related macular degeneration ...

Use of melatonin was associated with a decreased risk of development and progression of age-related macular degeneration (AMD), a retrospective cohort study suggested. Among propensity-matched ...

Melatonin use linked to reduced risk for developing AMD and for progression from nonexudative to exudative AMD. HealthDay News — Melatonin use is associated with a reduced risk for development and ...

A recent study published in JAMA Network Open reveals that higher levels of exposure to outdoor artificial light at night can increase the risk of incident exudative age-related macular degeneration.

Melatonin supplementation is linked to a reduced risk for developing age-related macular degeneration (AMD) and slowing its progression, suggesting potential as a preventive therapy. Researchers ...

The advent of second-generation anti-VEGF drugs is transforming the treatment of exudative age-related macular degeneration (AMD) due to their prolonged efficacy, which allows for fewer injections but ...

Please provide your email address to receive an email when new articles are posted on . In a retrospective study, researchers examined Korean Health Insurance Review and Assessment Service (HIRA) ...

Progression and severity of macular atrophy are the main anatomical determinants of long-term visual outcomes in exudative age-related macular degeneration (AMD) patients treated with ranibizumab, ...